http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 06 Jul 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/Press+Releases/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location> and <location value="LU/ca.qc.quebec" idsrc="xmltag.org" >QUEBEC CITY</location></span>, <span class="legendSpanClass"><chron>July 6, 2026</chron></span> /PRNewswire/ -- Global pharma major <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced its debut on TIME and Statista's World's Most Sustainable Companies 2026 list, recognizing the company's continued progress in environmental stewardship, responsible business practices, strong governance and positive social impact.</p> <div id="prni_dvprnejpgf423left" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpgf423left" style="width: 331px; height: 400px;" title="Lupin Limited Logo" src="https://mmx.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Limited Logo" align="middle" /></div><p>Lupin ranked 318^th among 750 companies selected from more http://www.streetinsider.com/PRNewswire/Lupin+Named+Among+World%27s+Most+Sustainable+Companies+by+TIME+and+Statista/26732915.html Mon, 06 Jul 2026 08:00:00 -0400 500257 500257 LUPIN LUPIN.BO LUPIN.NS O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/Press+Releases/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887 http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/in..bombay" idsrc="xmltag.org" >MUMBAI, India</location> and <location value="LU/us.fl.naples" idsrc="xmltag.org" >NAPLES, Fla.</location></span>, <span class="legendSpanClass"><chron>June 26, 2026</chron></span> /PRNewswire/ -- Global pharmaceutical leader <span value="Bombay:500257" idsrc="xmltag.org" >Lupin Limited</span> (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the <span>United States Food and Drug Administration</span> (<location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA) for its Abbreviated New Drug Application for Enzalutamide Tablets, 40 mg, 80 mg, 120 mg, and 160 mg.</p> <div id="prni_dvprnejpg85ealeft" dir="ltr" style="width: 100%; text-align: left;"><img id="prnejpg85ealeft" title="Lupin Logo" src="https://mma.prnewswire.com/media/2461104/Lupin_Logo.jpg" alt="Lupin Logo" align="middle" /></div><p>The <location value="LC/us" idsrc="xmltag.org" >U.S</location>. FDA has tentatively approved Lupin's Enzalutamide Tablets, http://www.streetinsider.com/PRNewswire/Lupin+Receives+Tentative+Approval+from+U.S.+FDA+for+Enzalutamide+Tablets/26695751.html Fri, 26 Jun 2026 09:31:00 -0400 500257 500257 A.01721546 LUPIN LUPIN.BO LUPIN.NS O.01520983 O.03319887